Is a complete PHIO research report available?

No complete published report is available for Phio Pharmaceuticals Corp. (PHIO) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Phio Pharmaceuticals Corp. (PHIO)

NASDAQ: PHIO · USD

$1.03

+0.05 (+4.7%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first PHIO analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	12M
Net income (ttm)	-10.9M
EPS (ttm)	-$1.40
Shares out	11.6M
Volume	82,975
Beta	0.81

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -10.9M
EPS (ttm): -$1.40
Market cap: 12M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All PHIO indicators

Market & fundamental data

Available fields

180

Groups with data

Currency

USD

Showing 180 of 180 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001533040
Company name	Phio Pharmaceuticals Corp.
Country	United States
Country code	US
Cusip	71880W501
Employees	6
Employees Change	1%
Employees Change Percent	20
Enterprise value	$-4.9M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US71880W5013
Last refreshed	2026-07-31
Market cap	$12M
Market cap category	Nano-Cap
Price	$1.03
Price currency	USD
Sector	Healthcare
Sector PE	45.21
Sector PE Fwd	23.64
Sic	2834
Symbol	PHIO
Website	https://phiopharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-90.48%
FCF yield	-88.7%
P/B ratio	0.69x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-6.5M
Net Income	$-10.9M
Net Income Growth Years	0%
Profit Per Employee	$-1.8M
ROA	-46.65
Roa5y	-48.55
ROCE	-69.95
ROE	-76.36
Roe5y	-89.49
ROIC	-50.27

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-69.33%
Cagr1y	-59.47%
Cagr3y	-65.42%
Cagr5y	-65.02%
EPS Growth Quarters	12
EPS Growth Years	13
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$17.4M
Cash	$17M
Current Assets	$17.4M
Current Liabilities	$950,000
Debt	$0
Equity	$16.5M
Liabilities	$950,000
Long Term Assets	$10,000
Long Term Liabilities	$0
Net Cash	$17M
Net Cash By Market Cap	$141
Net Cash Growth	28.26%
Net Debt Equity	$-1.03
Tangible Book Value	$16.5M
Tangible Book Value Per Share	$1.42
WACC	8.7

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	18.32
Net Working Capital	$-579,000
Quick ratio	17.93
Working Capital	$16.5M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-349.7%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-100%
1Y total return	-59.45%
200-day SMA	1.23
3Y total return	-95.87%
50-day SMA	1.05
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.48%
All Time High	6,381,461.7
All Time High Change	-100%
All Time High Date	2013-03-14
All Time Low	0.81
All Time Low Change	26.74%
All Time Low Date	2026-02-05
ATR	0.07
Beta	0.81
Beta1y	0.27
Beta2y	2.36
Ch YTD	-1.9
High	1.05
High52	4.19
High52 Date	2025-11-03
High52ch	-75.42%
Low	0.95
Low52	0.81
Low52 Date	2026-02-05
Low52ch	26.74%
Ma50ch	-2%
Premarket Change Percent	1.61
Premarket Price	$1
Premarket Volume	232
Price vs 200-day SMA	-15.99%
RSI	49.38
RSI Monthly	31.65
RSI Weekly	42.43
Sharpe ratio	-0.76x
Sortino ratio	-1.08
Total Return	-349.7%
Tr YTD	-1.9
Tr1m	4.57%
Tr1w	-3.74%
Tr3m	-12.71%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Earnings EPS Estimate	$-0.36
Operating Income	$-11.5M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	11,538,102%
Float Percent	99.32%
Shares Insiders	0.68%
Shares Institutions	10.81%
Shares Out	11,617,250
Shares Qo Q	24.13%
Shares Yo Y	349.7%
Short Float	1.54%
Short Ratio	0.12
Short Shares	1.53

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-11.5M
Adjusted OCF	-11,463,000
Average Volume	1,551,474.45x
Bv Per Share	1.42
CAPEX	$-10,000
Ch10y	-100
Ch1m	4.57
Ch1w	-3.74
Ch1y	-59.45
Ch3m	-12.71
Ch3y	-95.87
Ch5y	-99.48
Ch6m	0.98
Change	4.65%
Change From Open	4.64
Close	0.98
Days Gap	0.01
Depreciation Amortization	3,500
Dollar Volume	85,464.3
Earnings Date	2026-08-11
Earnings Time	amc
EBIT	$-11.5M
EBITDA	$-11.5M
EPS	$-1.4
F Score	2
FCF	$-10.7M
FCF EV Yield	216.55x
FCF Per Share	$-0.92
Financing CF	14,467,000
Fiscal Year End	December
Founded	2,003
Investing CF	-7,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Date	2024-07-05
Last Split Type	Reverse
Last10k Filing Date	2026-03-05
Ma150	1.12
Ma150ch	-8.04%
Ma20	1.03
Ma20ch	0.29%
Net CF	3,753,000
Next Earnings Date	2026-08-13
Open	0.98
Optionable	No
Position In Range	79.88
Post Close	1.03
Postmarket Change Percent	1.94
Postmarket Price	$1.05
Ppne	10,000
Pre Close	0.98
Price Date	2026-07-30
Ptbv Ratio	0.73
Relative Volume	0.05x
Share Based Comp	756,000
Tr6m	0.98%
Us State	Pennsylvania
Volume	82,975

Phio Pharmaceuticals Corp. (PHIO)

Coverage state: Market snapshot only — no published research

Generate the first PHIO analysis

Price

Financial snapshot

Fair-value bridge

Latest news · PHIO

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All PHIO indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on PHIO

Frequently asked questions